Oxbridge Re (OXBR) Competitors

NeueHealth (NYSE:NEUE) and Oxbridge Re (NASDAQ:OXBR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking and earnings.

Does the media favor NEUE or OXBR?

In the previous week, Oxbridge Re had 1 more articles in the media than NeueHealth. MarketBeat recorded 2 mentions for Oxbridge Re and 1 mentions for NeueHealth. NeueHealth's average media sentiment score of 0.98 beat Oxbridge Re's score of 0.35 indicating that NeueHealth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeueHealth	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Oxbridge Re	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has stronger earnings & valuation, NEUE or OXBR?

Oxbridge Re has lower revenue, but higher earnings than NeueHealth. Oxbridge Re is trading at a lower price-to-earnings ratio than NeueHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeueHealth	$936.66M	0.05	-$1.15B	-$22.63	-0.27
Oxbridge Re	$546K	21.89	-$9.91M	-$0.43	-3.73

Does the MarketBeat Community favor NEUE or OXBR?

Oxbridge Re received 196 more outperform votes than NeueHealth when rated by MarketBeat users. Likewise, 42.42% of users gave Oxbridge Re an outperform vote while only 0.00% of users gave NeueHealth an outperform vote.

Company	Underperform	Outperform
NeueHealth	Outperform Votes No Votes	Underperform Votes 2 100.00%
Oxbridge Re	Outperform Votes 196 42.42%	Underperform Votes 266 57.58%

Do institutionals and insiders hold more shares of NEUE or OXBR?

63.9% of NeueHealth shares are owned by institutional investors. Comparatively, 5.6% of Oxbridge Re shares are owned by institutional investors. 64.3% of NeueHealth shares are owned by insiders. Comparatively, 19.5% of Oxbridge Re shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has more risk and volatility, NEUE or OXBR?

NeueHealth has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500. Comparatively, Oxbridge Re has a beta of 1.29, indicating that its stock price is 29% more volatile than the S&P 500.

Do analysts prefer NEUE or OXBR?

NeueHealth presently has a consensus target price of $7.00, indicating a potential upside of 12.81%. Given NeueHealth's stronger consensus rating and higher probable upside, equities research analysts clearly believe NeueHealth is more favorable than Oxbridge Re.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeueHealth	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Oxbridge Re	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is NEUE or OXBR more profitable?

Oxbridge Re has a net margin of 0.00% compared to NeueHealth's net margin of -36.28%. NeueHealth's return on equity of -6.40% beat Oxbridge Re's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeueHealth	-36.28%	-6.40%	8.45%
Oxbridge Re	N/A	-114.38%	-64.42%

Summary

NeueHealth beats Oxbridge Re on 9 of the 17 factors compared between the two stocks.